IMARX THERAPEUTICS, INC. SC 13G

Company

BOSTON SCIENTIFIC CORP

Filed

February 14, 2008

Accession Number

0001072613-08-000470

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →